Nabla offers an agentic clinical AI assistant that combines ambient listening, dictation, coding, and EHR command capabilities into a single platform integrated with major EHRs. The product is built on a domain-specific large language model refined with clinically grounded data and a robust evaluation framework. Nabla supports more than 85,000 clinicians across 130+ healthcare organizations, processes over 30 billion tokens monthly, and handles about 20 million annual encounters. The company reports revenue multiplied by five over the past six months and delivers measurable ROI via reduced documentation time, lower clinician burnout, and higher patient satisfaction. Its assistant is available in 35 languages and is deployed across ambulatory, behavioral health, pediatric, emergency, and early inpatient and nursing workflows. Future plans include an Adaptive Agentic Platform with a Proactive Coding Agent, Context-Aware Agent for EHR actions and orders, and Custom Care Setting Agents tailored for nurses and other frontline roles. Nabla is a Paris-based startup building an AI copilot that listens to consultations and automatically generates medical reports and clinical notes. It uses speech-to-text (Microsoft Azure plus a fine-tuned Whisper-based model), pseudonymizes transcripts, processes them with large language models (historically GPT-3 and GPT-4 and experiments with fine-tuned Llama 2), and then de-pseudonymizes output so doctors can review and export notes to EHRs. Physicians can edit reports before they are filed and customize formats (including SOAP notes). Nabla emphasizes data processing over storage, discarding audio and not storing notes without doctor and patient consent. The company has a large-scale partnership with Permanente Medical Group and says most customers are in the U.S.; thousands of doctors use the product daily and it is on track to process more than 3 million consultations per year in three languages. Financially, Nabla just raised a new funding round and reached a reported valuation of $180 million after the latest financing. Nabla offers a women’s-health focused app that lets users message general practitioners, gynecologists, midwives, nurses, nutritionists and physiotherapists and view a personal log of past interactions. The app centralizes medical data and can connect with Apple Health, Clue and Withings. Nabla currently provides a free tier with a limited number of monthly text questions, alongside curated community content reviewed by its doctors. The company emphasizes machine learning for preventive and personalized care, with data sharing opt-in for users. Founders include Alexandre Lebrun, Delphine Groll and Martin Raison, who have prior exits and experience at companies like Wit.ai and Facebook; Nabla is working with a team of doctors to serve early users. The startup plans to launch telemedicine appointments and a premium offering in future releases.

Total raised

$114M

Funding rounds

3

Latest round

Series C

Latest activity

Jun 2025